Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
10.18
-0.82 (-7.45%)
At close: Jun 5, 2026, 4:00 PM EDT
9.95
-0.23 (-2.26%)
After-hours: Jun 5, 2026, 4:10 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $398 million as of June 5, 2026. Its market cap has increased by 483.02% in one year.
Market Cap
398.00M
Enterprise Value
415.42M
1-Year Change
483.02%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $398.00M, a decrease of -28.09%. That is a compound annual growth rate of -11.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 440.00M | 739.73% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 471.15M |
| Ocugen | 463.77M |
| Ovid Therapeutics | 462.87M |
| Contineum Therapeutics | 459.85M |
| C4 Therapeutics | 459.45M |
| Editas Medicine | 458.85M |
| Autolus Therapeutics | 441.80M |
| Sagimet Biosciences | 435.97M |